BioLargo, Inc. (BLGO) stock
BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
$0.07+0.00 (+0.90%)
Close on Oct 19, 2026Market cap $23.27MP/E –Yield –
BioLargo total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
BioLargo's total debt was $83.00K at Sep 30, 2025. For fiscal 2024 it was $66.00K, down 81.4% from the year before. The highest annual figure on record is $6.79M in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $66.00K | -81.4% |
| FY2023 | Dec 31, 2023 | $355.00K | +5.3% |
| FY2022 | Dec 31, 2022 | $337.00K | -31.8% |
| FY2021 | Dec 31, 2021 | $494.00K | -71.2% |
| FY2020 | Dec 31, 2020 | $1.71M | -64.0% |
| FY2019 | Dec 31, 2019 | $4.76M | +36.4% |
| FY2018 | Dec 31, 2018 | $3.49M | -48.6% |
| FY2017 | Dec 31, 2017 | $6.79M | +16.8% |
| FY2016 | Dec 31, 2016 | $5.81M | +79.0% |
| FY2015 | Dec 31, 2015 | $3.25M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $83.00K | -66.8% |
| Q2 FY2025 | Jun 30, 2025 | $83.00K | -76.3% |
| Q4 FY2024 | Dec 31, 2024 | $66.00K | -81.4% |
| Q3 FY2024 | Sep 30, 2024 | $246.00K | -31.5% |
| Q2 FY2024 | Jun 30, 2024 | $250.00K | -31.5% |
| Q1 FY2024 | Mar 31, 2024 | $350.00K | -4.9% |
| Q4 FY2023 | Dec 31, 2023 | $355.00K | +5.3% |
| Q3 FY2023 | Sep 30, 2023 | $359.00K | +7.8% |
| Q2 FY2023 | Jun 30, 2023 | $365.00K | +11.3% |
| Q1 FY2023 | Mar 31, 2023 | $368.00K | +13.6% |
| Q4 FY2022 | Dec 31, 2022 | $337.00K | -31.8% |
| Q3 FY2022 | Sep 30, 2022 | $333.00K | -31.9% |
| Q2 FY2022 | Jun 30, 2022 | $328.00K | -32.4% |
| Q1 FY2022 | Mar 31, 2022 | $324.00K | -65.1% |
| Q4 FY2021 | Dec 31, 2021 | $494.00K | -71.2% |
| Q3 FY2021 | Sep 30, 2021 | $489.00K | -83.1% |
| Q2 FY2021 | Jun 30, 2021 | $485.00K | -90.3% |
| Q1 FY2021 | Mar 31, 2021 | $929.00K | -82.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.71M | -64.0% |
| Q3 FY2020 | Sep 30, 2020 | $2.89M | -59.9% |
| Q2 FY2020 | Jun 30, 2020 | $4.99M | -1.0% |
| Q1 FY2020 | Mar 31, 2020 | $5.33M | +25.9% |
| Q4 FY2019 | Dec 31, 2019 | $4.76M | +36.4% |
| Q3 FY2019 | Sep 30, 2019 | $7.21M | +217.0% |
| Q2 FY2019 | Jun 30, 2019 | $5.04M | +204.8% |
| Q1 FY2019 | Mar 31, 2019 | $4.23M | -40.9% |
| Q4 FY2018 | Dec 31, 2018 | $3.49M | -48.6% |
| Q3 FY2018 | Sep 30, 2018 | $2.27M | -64.0% |
| Q2 FY2018 | Jun 30, 2018 | $1.65M | -69.9% |
| Q1 FY2018 | Mar 31, 2018 | $7.17M | +24.4% |
| Q4 FY2017 | Dec 31, 2017 | $6.79M | +16.8% |
| Q3 FY2017 | Sep 30, 2017 | $6.31M | +15.8% |
| Q2 FY2017 | Jun 30, 2017 | $5.51M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.76M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.81M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.45M | – |
See a number that looks wrong?